Nalaganje...
Treating Hepatic Steatosis and Fibrosis by Modulating Mitochondrial Pyruvate Metabolism
A hepatic comorbidity of metabolic syndrome, known as nonalcoholic fatty liver disease (NAFLD), is increasing in prevalence in conjunction with the pandemics of obesity and diabetes. The spectrum of NAFLD ranges from simple hepatic fat accumulation to a more severe disease termed nonalcoholic steato...
Shranjeno v:
| izdano v: | Cell Mol Gastroenterol Hepatol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6352854/ https://ncbi.nlm.nih.gov/pubmed/30686780 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcmgh.2018.09.017 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|